Physician profile
Kristen Pace
NPI 1497419436
$440.42
in general payments reported to CMS, 2019-2025
14 companies · $24.50 in 2025
The $24.50 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.73 · 2023: $182 · 2024: $170 · 2025: $24.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $62.98 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $55.85 | 2024-2025 | |
| Pfizer INC. | $48.00 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $42.88 | 2023-2024 | Farxiga |
| Glaxosmithkline, LLC. | $32.82 | 2023-2024 | Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $30.20 | 2023-2024 | Spravato |
| Acadia Pharmaceuticals INC | $26.62 | 2024 | Daybue |
| Otsuka America Pharmaceutical, INC. | $24.91 | 2024 | Rexulti |
| Xeris Pharmaceuticals, INC. | $24.88 | 2023 | Gvoke Hypopen |
| Antares Pharma, INC. | $22.12 | 2023 | Nocdurna, Xyosted, Tlando |
| Takeda Pharmaceuticals U.S.A., INC. | $19.65 | 2022 | |
| Lilly USA, LLC | $19.33 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.38 | 2023 | Eliquis |
| Teva Pharmaceuticals USA, INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Pace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.